Table 1.
Characteristic (n = 515) | No. (%) |
---|---|
Age, y | |
35-39 | 100 (19.4) |
40-49 | 146 (28.3) |
50-59 | 123 (23.9) |
60-69 | 80 (15.5) |
70-79 | 50 (9.7) |
80-89 | 16 (3.1) |
Sex | |
Male | 206 (40) |
Female | 309 (60) |
Wealth quintile | |
1 (lowest) | 122 (23.7) |
2 | 104 (20.2) |
3 | 139 (27.0) |
4 | 76 (14.8) |
5 (highest) | 74 (14.4) |
HIV status | |
Positive | 199 (38.6) |
Current ART usea (% of total HIV-positive individuals) | 164 (82.4) |
Viral load suppression, HIV RNA <1000/mL (% of total HIV-positive individuals) | 164 (82.4) |
CD4 cell count <200/mL (% of total HIV-positive individuals) | 17 (8.5) |
CD4 cell count 200-500/mL (% of total HIV-positive individuals) | 63 (31.7) |
CD4 cell count >500/mL (% of total HIV-positive individuals) | 119 (60.0) |
Negative | 316 (61.4) |
Current ART use based on ART detection assays. ART = antiretroviral therapy.